23 results match your criteria: "hôpitaux universitaires Pitié-Salpêtrière - Charles-Foix[Affiliation]"

Article Synopsis
  • The study investigates the reemergence of Kaposi sarcoma (KS) in people living with HIV who are on antiretroviral therapy (ART), suggesting that age-related immune decline (immunosenescence) may play a role.
  • Researchers compared data, including immune responses and viral factors, from both HIV KS patients and classic KS patients who are HIV-uninfected, while also including age-matched controls.
  • Findings indicate that despite younger ages and favorable CD4 counts in HIV KS patients, their immune profiles are similar to those of older cKS patients, pointing towards the need for new strategies to prevent and treat KS in individuals receiving ART.
View Article and Find Full Text PDF
Article Synopsis
  • - Cardiometabolic disorders significantly contribute to cardiovascular diseases, with sphingosine-1-phosphate (S1P) and its receptors (S1PRs) playing crucial roles in maintaining heart health through complex signaling pathways.
  • - S1P is transported in the bloodstream by carriers such as high-density lipoprotein and albumin, allowing it to influence various essential processes like cardiac contractility, inflammation, and angiogenesis.
  • - The review highlights the roles of S1P/S1PRs in heart diseases and explores therapeutic potential, including the drug Fingolimod, while discussing the challenges of developing new treatments that target these receptors.
View Article and Find Full Text PDF
Article Synopsis
  • Most drugs struggle to effectively treat glioblastoma (GBM) due to limited penetration across the blood-brain barrier, which makes their efficacy low.
  • This study utilizes low-intensity pulsed ultrasound (LIPU) combined with microbubbles (MB) to temporarily open the blood-brain barrier, significantly increasing the delivery of liposomal doxorubicin and PD-1 blocking antibodies (aPD-1) in both human and animal models.
  • Results show that this method improves drug concentrations, enhances immune responses in cells, and contributes to long-term survival in GBM mouse models, highlighting its potential for improving GBM treatments.
View Article and Find Full Text PDF

Early-Stage Contactin-Associated Protein-like 2 Limbic Encephalitis: Clues for Diagnosis.

Neurol Neuroimmunol Neuroinflamm

January 2023

From the French Reference Center on Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis (J.B., S.M.-C., A.V., A.F., A.-L.P., G.P., V.R., J.H., B.J.), Hospices Civils de Lyon; Synaptopathies and Autoantibodies (SynatAc) Team (J.B., S.M.-C., A.V., A.F., A.-L.P., G.P., V.R., J.H., B.J.), Institut NeuroMyoGène, MELIS, INSERM U1314/CNRS UMR 5284, Université Claude Bernard Lyon 1; Epileptology-EEG Department (J.B.), Neurology, Pasteur2 Hospital, University Hospitals of Nice; Côte d'Azur University (J.B.), UR2CA, URRIS, Pasteur2 Hospital, University Hospitals of Nice; Department of Functional Neurology and Epileptology (D.G., S.R.), Hospices Civils de Lyon, France; European Network for Rare and Complex Epilepsies (EPICARE) (D.G., S.R.); Service de Neurologie 2-Mazarin (A.A., D.P.), Hôpitaux Universitaires La Pitié-Salpêtrière-Charles Foix, APHP; Inserm U1127 CNRS UMR 7225 (A.A., D.P.), Institut Du Cerveau et de la Moelle épinière, ICM, Université Pierre-et-Marie-Curie, Sorbonne Universités, Paris; and Lyon's Neuroscience Research Center (S.R.), INSERM U1028/CNRS UMR 5292; Université Lyon 1 Claude Bernard, France.

Background And Objectives: Previous studies suggested that autoimmune limbic encephalitis with antibodies against contactin-associated protein-like 2 (CASPR2-encephalitis) is clinically heterogeneous and progresses slowly, preventing its early recognition. We aimed to describe the onset and progression of CASPR2-encephalitis and to assess long-term outcomes.

Methods: We retrospectively analyzed the medical records of all patients whose CSF tested positive for anti-CASPR2 antibodies in our center between 2006 and 2020.

View Article and Find Full Text PDF

An N-heterocyclic carbene iridium(III) complex as a potent anti-cancer stem cell therapeutic.

Chem Biol Interact

November 2022

3Bio Team, CAMB UMR7199 CNRS-Université de Strasbourg, Faculté de Pharmacie, 74 route du Rhin, F-67401 Illkirch cedex, France. Electronic address:

Cancer stem cells (CSCs) represent a difficult to treat cellular niche within tumours due to their unique characteristics, which give them a high propensity for resistance to classical anti-cancer treatments and the ability to repopulate the tumour mass. An attribute that may be implicated in the high rates of recurrence of certain tumours. However, other characteristics specific to these cells, such as their high dependence on mitochondria, may be exploited for the development of new therapeutic agents that are effective against the niche.

View Article and Find Full Text PDF

Activation of cyclin-dependent kinases (CDKs) contributes to the uncontrolled proliferation of tumour cells. Genomic alterations that lead to the constitutive activation or overexpression of CDKs can support tumourigenesis including glioblastoma (GBM), the most common and aggressive primary brain tumour in adults. The incurability of GBM highlights the need to discover novel and more effective treatment options.

View Article and Find Full Text PDF

Background: Patients with SARS-CoV-2 infection are at higher risk for ventilator-associated pneumonia (VAP). No study has evaluated the relationship between VAP and mortality in this population, or compared this relationship between SARS-CoV-2 patients and other populations. The main objective of our study was to determine the relationship between VAP and mortality in SARS-CoV-2 patients.

View Article and Find Full Text PDF

Background: IDH-mutant anaplastic astrocytomas (AAs) are chemosensitive tumors for which the best choice of adjuvant chemotherapy between procarbazine, lomustine, and vincristine (PCV) or temozolomide (TMZ) after radiotherapy (RT) remains unclear.

Methods: In a large cohort of patients with histologically proven 2016 World Health Organization classification AA with IDH1/2 mutations included in the French national POLA cohort (n = 355), the primary objective was to compare progression-free survival (PFS) between the two treatment regimens (n = 311). Secondary endpoints were overall survival (OS), progression type, pseudoprogression rate, and toxicity.

View Article and Find Full Text PDF

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Oncologist

November 2020

Sorbonne Université, INSERM, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) S 1127, Institut du Cerveau et de la Moelle épinière (ICM), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix Service de Neurologie 2-Mazarin, Paris, France.

Article Synopsis
  • Glioblastoma (GBM) is an aggressive brain tumor that can lead to a serious complication known as leptomeningeal spread (LMS), complicating both diagnosis and treatment options.
  • A review of literature from 1989 to 2019 revealed that diagnosing LMS in GBM is challenging with a low cytological confirmation rate and poor survival outcomes, emphasizing the need for advanced diagnostic methods like MRI and cerebrospinal fluid analysis.
  • The study suggests that a personalized treatment approach, combining surgery, chemotherapy, and emerging therapies, may benefit some patients with LMS, highlighting the importance of further research and clinical trials to improve management strategies.
View Article and Find Full Text PDF

Purpose: Although patients with SARS-CoV-2 infection have several risk factors for ventilator-associated lower respiratory tract infections (VA-LRTI), the reported incidence of hospital-acquired infections is low. We aimed to determine the relationship between SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, and the incidence of VA-LRTI.

Methods: Multicenter retrospective European cohort performed in 36 ICUs.

View Article and Find Full Text PDF

Blood product needs and transfusion timelines for the multisite massive Paris 2015 terrorist attack: A retrospective analysis.

J Trauma Acute Care Surg

September 2020

From the Department of Anaesthesiology and Critical Care (T.M., S.A.), Percy Military Hospital, Clamart; French Blood Institute (A.F.), Paris, France; French Military Blood Institute (T.P.), Clamart, France; SAMU 75 (P.C.), Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; SAMU 93 (F.L.), Hôpital Avicenne, Assistance Publique-Hôpitaux de Paris, Bobigny, France; Department of Anaesthesiology and Critical Care (T.G.), Hôpital Beaujon, Hôpitaux Universitaires Paris Nord-Val-De-Seine, Assistance Publique-Hôpitaux de Paris, Clichy, France; Université Paris Sud, Department of Anesthesiology and Critical Care (S.R.H.), Assistance Publique-Hôpitaux de Paris, Bicêtre Hôpitaux Universitaires Paris Sud, Le Kremlin Bicêtre, France; CESP, INSERM, Université Paris-Sud (S.R.H.), UVSQ, Université Paris-Saclay, France; CESP, INSERM, Maison de Solenn (S.R.H.), France; Service Médical du RAID (M.L.), Bièvres, France; Groupe Hospitalier Pitié-Salpêtrière-Charles Foix, Department of Anaesthesiology and Critical Care (M.L., E.D., M.R.), Groupe Hospitalier Pitié-Salpêtrière-Charles Foix, Department of Emergency Medicine and Surgery (B.R.), Hôpital Saint-Antoine, Department of Emergency (Y.Y., D.P.), France, Hôpital Européen Georges Pompidou, Emergency Department (A.-L.F.-P.), Assistance Publique-Hôpitaux de Paris, Paris, France; Begin Military Hospital, Department of Emergency (A.W.), Saint Mandé, France; Hôpital Saint Louis, Department of Emergency (C.O.), Hôpital Lariboisière, Department of Anesthesiology and Critical Care (E.G.), Assistance Publique-Hôpitaux de Paris, Paris, France; Hôpital Henri Mondor, Department of Anaesthesiology and Critical Care (A.A.), Assistance Publique-Hôpitaux de Paris, Créteil, France; Hôpital Bichat, Division of Vascular Surgery (Y.C.), Assistance Publique-Hôpitaux de Paris, Paris, France; Institut Médico-légal de Paris (B.L.), Paris, France; Paris Fire Brigade, Emergency Medical Department (J.-P.T.), Paris, France; French Military Health Service Schools (S.A.), Lyon, France; Université Paris Diderot (E.G., Y.C.), Paris, France; Université Paris Descartes (P.C., B.L.), Paris, France; Université Paris 13 (F.L.), Bobigny, France; Sorbonne Université (M.R.), UMRS Inserm 1158, France; Sorbonne Université (D.P., B.R.), UMRS Inserm 1166, IHU ICAN, Paris, France; and Sorbonne Université (Y.Y.), UMRS Inserm 1136, Paris, France.

Objective: Hemorrhage is the leading cause of death after terrorist attack, and the immediacy of labile blood product (LBP) administration has a decisive impact on patients' outcome. The main objective of this study was to evaluate the transfusion patterns of the Paris terrorist attack victims, November 13, 2015.

Methods: We performed a retrospective analysis including all casualties admitted to hospital, aiming to describe the transfusion patterns from admission to the first week after the attack.

View Article and Find Full Text PDF

Combining bacteriophages and dalbavancin for salvage therapy of complex Staphylococcus aureus extradural empyema.

Med Mal Infect

August 2020

Department of Neurosurgery, groupe hospitalier Pitié-Salpêtrière, AP-HP, Paris, France; Sorbonne université, Experimental Neuro-Oncology Unit, CRICM INSERM U1127 CNRS UMR 7225, ICM, 75013 Paris, France.

View Article and Find Full Text PDF

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.

Neurology

June 2019

From the University Medical Center & German Cancer Research Center (M.N., F.S., I.H., P.K., M.P., M.B., W.W.), Heidelberg, Germany; EORTC Headquarters (T.G., V.G.), Brussels, Belgium; Brain Tumor Center at Erasmus MC Cancer Institute (J.E.C.B., W.T., M.J.v.d.B.), Rotterdam, the Netherlands; Medical Oncology Department (A.A.B.), AUSL-Bologna-IRCCS Scienze Neurologiche, Bologna, Italy; Haaglanden Medical Center (M.J.B.T.), the Hague; Leiden University Medical Center (M.J.B.T.), the Netherlands; Institut Gustave Roussy (J.D.), Villejuif; Sorbonne Université (A.I.), Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle Épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, Paris; Institut de Cancerologie de l'Ouest (ICO)-Centre Rene Gauducheau (M.C.), Saint-Herblain, France; Leuven Cancer Institute-KU Leuven (P.M.C.), Belgium; Department of Neurology and Brain Tumor Center (M.W.), University Hospital and University of Zurich, Switzerland; Institut Régional du Cancer Montpellier (M.F.); University of Lille (E.L.R.), U-1192, Inserm; CHU Lille (E.L.R.), General and Stereotaxic Neurosurgery Service; Oscar Lambret Center (E.L.R.), Neurology, Lille, France; Department of Neurology (M.P.), Medical Faculty Mannheim, Heidelberg University, Germany; and Department of Neurology (M.N.), Medical University Innsbruck, Austria.

Objective: Imaging necrosis on MRI scans was assessed and compared to outcome measures of the European Organisation for Research and Treatment of Cancer 26101 phase III trial that compared single-agent lomustine with lomustine plus bevacizumab in patients with progressive glioblastoma.

Methods: MRI in this post hoc analysis was available for 359 patients (lomustine = 127, lomustine + bevacizumab = 232). First, imaging necrosis at baseline being formally measurable (>10 × 10 mm, given 2 slices) was assessed.

View Article and Find Full Text PDF

Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are limited to antibiotics with severe side effects. Here, we show that M.

View Article and Find Full Text PDF

Lomustine and Bevacizumab in Progressive Glioblastoma.

N Engl J Med

November 2017

From the University Medical Center and German Cancer Research Center, Heidelberg, Germany (W.W., M.B., F.S., I.H., A.D., M.P.); the European Organization for Research and Treatment of Cancer, Brussels (T.G., V.G.), and Leuven Cancer Institute-KU Leuven, Leuven (P.M.C.) - both in Belgium; Haaglanden Medical Center, The Hague (M.T.), Erasmus MC Cancer Institute, Rotterdam (W.T., J.C.B., M.J.B.), and VU University Medical Center, Amsterdam (M.K.) - all in the Netherlands; the Medical Oncology Department, Azienda Unità Sanitaria Locale di Bologna-IRCCS Istituto delle Scienze Neurologiche, Bologna, Italy (A.A.B.); Institut Gustave Roussy, Villejuif (J.D.), Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Service de Neurologie 2-Mazarin, INSERM Unité 1127, Centre National de la Recherche Scientifique Unité Mixte de Recherche (UMR) 7225, Sorbonne Universités, University Pierre and Marie Curie 06 UMR S1127, and Institut du Cerveau et de la Moelle Épinière, Paris (A.I.), Institut de Cancerologie de l'Ouest-Centre Rene Gauducheau, Saint-Herblain (M.C.), Institut Régional du Cancer Montpellier, Montpellier (M.F.), and Centre Hospitalier Régional Universitaire de Lille, Lille (E.L.R., F.D.) - all in France; and the Departments of Oncology and Neurology, University Hospital and University of Zurich, Zurich, Switzerland (R.S., M.W.).

Background: Bevacizumab is approved for the treatment of patients with progressive glioblastoma on the basis of uncontrolled data. Data from a phase 2 trial suggested that the addition of bevacizumab to lomustine might improve overall survival as compared with monotherapies. We sought to determine whether the combination would result in longer overall survival than lomustine alone among patients at first progression of glioblastoma.

View Article and Find Full Text PDF

Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.

Antiviral Res

October 2017

Service d'Ophtalmologie, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Université Paris-Sud, DHU Vision et Handicaps, 78, rue du Général Leclerc, 94275 Le Kremlin Bicêtre, France; Service d'Immunologie des Infections Virales et des Maladies Auto-immunes (IMVA), 18, Route du Panorama, 92260 Fontenay-aux-Roses, France. Electronic address:

Recurrent herpes simplex keratitis (HSK) is a leading infectious cause of blindness in industrialized countries. Antiviral prophylaxis (AVP) may fail to prevent recurrence of HSK due to viral resistance, inadequate dosing, or poor patient compliance. In this prospective multicenter study, we enrolled immunocompetent patients with recurrent HSK despite AVP.

View Article and Find Full Text PDF

Tangential migration of corridor guidepost neurons contributes to anxiety circuits.

J Comp Neurol

February 2018

IBENS, Département de Biologie, École normale supérieure, CNRS, Inserm, PSL Research University, Paris, France.

In mammals, thalamic axons are guided internally toward their neocortical target by corridor (Co) neurons that act as axonal guideposts. The existence of Co-like neurons in non-mammalian species, in which thalamic axons do not grow internally, raised the possibility that Co cells might have an ancestral role. Here, we investigated the contribution of corridor (Co) cells to mature brain circuits using a combination of genetic fate-mapping and assays in mice.

View Article and Find Full Text PDF

Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.

Lancet Oncol

September 2017

Department of Radiation Therapy, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif, France.

Background: The Meta-Analysis of Radiotherapy in squamous cell Carcinomas of Head and neck (MARCH) showed that altered fractionation radiotherapy is associated with improved overall and progression-free survival compared with conventional radiotherapy, with hyperfractionated radiotherapy showing the greatest benefit. This update aims to confirm and explain the superiority of hyperfractionated radiotherapy over other altered fractionation radiotherapy regimens and to assess the benefit of altered fractionation within the context of concomitant chemotherapy with the inclusion of new trials.

Methods: For this updated meta-analysis, we searched bibliography databases, trials registries, and meeting proceedings for published or unpublished randomised trials done between Jan 1, 2009, and July 15, 2015, comparing primary or postoperative conventional fractionation radiotherapy versus altered fractionation radiotherapy (comparison 1) or conventional fractionation radiotherapy plus concomitant chemotherapy versus altered fractionation radiotherapy alone (comparison 2).

View Article and Find Full Text PDF

Magnetic hyperthermia was reported to increase the survival of patients with recurrent glioblastoma by 7 months. This promising result may potentially be further improved by using iron oxide nanoparticles, called magnetosomes, which are synthesized by magnetotactic bacteria, extracted from these bacteria, purified to remove most endotoxins and organic material, and then coated with poly-l-lysine to yield a stable and non-pyrogenic nanoparticle suspension. Due to their ferrimagnetic behavior, high crystallinity and chain arrangement, these magnetosomes coated with poly-l-lysine (M-PLL) are characterized by a higher heating power than their chemically synthesized counterparts currently used in clinical trials.

View Article and Find Full Text PDF

Unlabelled: Essentials Hemorrhagic risk of antiplatelet drugs is generally thought to be lower than anticoagulants. We systematically reviewed trials comparing antiplatelet and anticoagulant drugs in older patients. Overall, the risk of major bleeding was similar with antiplatelet and with anticoagulant drugs.

View Article and Find Full Text PDF

Background: Carbapenemase-producing Enterobacteriaceae (CPE) are difficult to identify among carbapenem non-susceptible Enterobacteriaceae (NSE). We designed phenotypic strategies giving priority to high sensitivity for screening putative CPE before further testing.

Methods: Presence of carbapenemase-encoding genes in ertapenem NSE (MIC > 0.

View Article and Find Full Text PDF

Sterilizing Activity of Fully Oral Intermittent Regimens against Mycobacterium Ulcerans Infection in Mice.

PLoS Negl Trop Dis

October 2016

Sorbonne Universités, UPMC Univ Paris 06, CR7, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI, Team E13 (Bactériologie), F-75013, Paris, France.

Background: The treatment of Buruli ulcer (BU) that is caused by Mycobacterium ulcerans, is currently based on a daily administration of rifampin and streptomycin (RIF-STR). A fully oral intermittent regimen would greatly simplify its treatment on the field.

Methodology/principal Findings: The objective of this study was to assess the bactericidal and sterilizing activities of intermittent oral regimens in a murine model of established M.

View Article and Find Full Text PDF

Human Herpesviruses 6A, 6B, and 7.

Microbiol Spectr

June 2016

Sorbonne Universités, UPMC, CIMI-Paris UMRS CR7, PVI Team, Paris, France.

Article Synopsis
  • - Human roseoloviruses, including HHV-6A, HHV-6B, and HHV-7, are herpesviruses that can cause lifelong latent infections and are known to impact a range of body systems, particularly in immunocompromised individuals.
  • - About 1% of the general population has HHV-6 DNA integrated into their chromosomes, and while many infections are asymptomatic, they can lead to serious diseases like encephalitis, especially in hematopoietic stem cell transplant recipients.
  • - Diagnosing these infections typically involves quantifying viral DNA through PCR, and while antiviral treatments exist, there is no consensus on when to use them or how to administer them effectively, leaving many questions
View Article and Find Full Text PDF